期刊文献+

π-氧化樟脑的合成 被引量:1

Synthesis of π-Oxocamphor
下载PDF
导出
摘要 以(+)-樟脑为原料,先经二次溴化、还原得(+)-π-溴代樟脑,再经酯化、水解和氧化反应合成了强心药物π-氧化樟脑。确定了较佳工艺条件:(1)溴化反应:n〔(+)-樟脑〕∶n(Br2)=1∶1.4,冰醋酸为溶剂,80℃下反应6h,(+)-α-溴代樟脑收率88.5%;n〔(+)-α-溴代樟脑〕∶n(Br2)=1∶1.1,氯磺酸为助剂,室温下反应2 h,(+)-α,π-二溴代樟脑收率80.1%。(2)还原反应:n〔(+)-α,π-二溴代樟脑〕∶n(Zn)=1∶3,冰醋酸为溶剂,冰浴反应3h,(+)-π-溴代樟脑收率66.3%。(3)酯化-水解反应:n〔(+)-π-溴代樟脑〕∶n(CH3COOK)=1∶1.5,冰醋酸为溶剂,190℃下反应30 h,除去溶剂后用V(CH3CH2OH)∶V〔w(KOH)=55%的水溶液〕=1∶9的水解液,回流反应2.5 h,(+)-π-羟基樟脑收率78.1%。(4)氧化反应:选用氯铬酸吡啶嗡盐(PCC)作氧化剂,n(PCC)∶n〔(+)-π-羟基樟脑〕=2∶1,CH2Cl2作溶剂,氮气保护下室温反应2 h,π-氧化樟脑收率95.5%。目标产物总收率35%。中间体及目标产物结构经IR、GC-MS和1HNMR确证。 π-Oxocamphor in a total yield of 35% was synthesized by esterification,hydrolysis and oxidation from(+)-π-bromocamphor which was prepared from(+)-camphor by twice bromination and reduction reaction.The optimum reaction conditions were ascertained as follows:(1)Bromination:n((+)-camphor)∶n(bromine)=1∶1.4,glacial acetic acid as solvent,reaction time being 6 h at 80 ℃,the yield of(+)-α-bromination camphor was 88.5%;n((+)-α-bromination camphor)∶n(bromine)=1∶1.1,chlorosulfonic acid as adjuvant,reaction time being 2 h at room temperature,the yield of(+)-α,π-dibromination camphor was 80.1%.(2)Reduction:n((+)-α,π-dibromination camphor)∶n(zinc)=1∶3,glacial acetic acid as solvent,ice bath response for 3 h,the yield of(+)-π-bromination camphor was 66.3%.(3)Esterification-hydrolysis:n((+)-π-bromination camphor)∶n(potassium acetate)=1∶1.5,glacial acetic acid as solvent,esterification reaction time being 30 h at 190 ℃.Then,the solvent was removed,and the reaction took place at reflux temperature in the hydrolysate(V(CH3CH2OH) ∶V(mass fraction 55% potassium hydroxide)=1∶9) for about 2.5 h to give the(+)-π-hydroxyl camphor in a yield of about 78.1%.(4)Oxidation:chlorine pyridine chromium acid salt(PCC) as oxygenant,n(PCC)∶n((+)-π-hydroxyl camphor)=2∶1,CH2Cl2 as solvent,under the protection of nitrogen,the reactants reacted for 2 h at room temperature,and the yield of π-oxocamphor was 95.5%.The structure of the intermediates and the target products was confirmed by IR,GC-MS and 1HNMR.
出处 《精细化工》 EI CAS CSCD 北大核心 2012年第4期361-365,共5页 Fine Chemicals
关键词 π-氧化樟脑 强心药 医药与日化原料 π-oxocamphor cardiotonic drug drug and cosmetic materials
  • 相关文献

参考文献13

二级参考文献32

共引文献22

同被引文献8

  • 1张银娣,吴澜宇.刘天培.附子毒性的研究[J].药学学报,1966,5(13):350-352. 被引量:1
  • 2韩慧婉,王家珍,孙福立,等.去甲乌药碱对培养心肌细胞搏动的影响[J].中国药理学报.1981,2(2):111-114. 被引量:1
  • 3Chang W S, Lee Y S, Kang Y J, et al. Physiol [J]. Pharmacol, 1998, 2: 323. 被引量:1
  • 4Harris J M , Liu Y , Chai S , et al. Modification of the swem oxidation: use of a soluble polymer-bound, recyclable, and odorless sulfoxide[J]. Org Chem, 1998, 63:2 407-2 409. 被引量:1
  • 5刘天培,潘鑫.中国乌头对血管的作用[J].药学学报,1996,13(4):250—251. 被引量:1
  • 6Tomas H. Improved synthesis and characterization of pietet- spengler adducts of phenyl pyruvic acid and biogenie amines [J]. Org Chem, 1981, 46:1 738-1 740. 被引量:1
  • 7Tram G L. The total synthesis of (+)-puupehenone[J]. Tetrahedron letter, 1978, 18:1 525-1 528. 被引量:1
  • 8Pyo M K, Yun-Choi H S, Chang K C, et al. Arzneim. -Forsch [J]. / Drug Res. 2004, 54: 705. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部